Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Guacetisal
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.221 |
Chemical and physical data | |
Formula | C16H14O5 |
Molar mass | 286.283 g·mol−1 |
3D model (JSmol) | |
Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
|
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases. Chemically, it is an ester resulting from the combination of aspirin and guaiacol.
pyrazolones / pyrazolidines |
|
---|---|
salicylates | |
acetic acid derivatives and related substances |
|
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) |
|
COX-2 inhibitors (coxibs) |
|
other | |
NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |